Caileigh Dougherty | Director, Investor Relations |
Johnson Lau | Chief Executive Officer |
Dan Lang | President, Athenex Cell Therapy |
Darrel Cohen | Chief Medical Officer, Cell Therapy |
Jeff Yordon | Chief Operating Officer |
Joe Annoni | Chief Financial Officer |
Faisal Khurshid | SVB Securities |
Jon Miller | Evercore |
Matt Kaplan | Ladenburg Thalmann |
Yale Jen | Laidlaw & Co |
Good day, ladies and gentlemen and welcome to the Second Quarter 2022 Athenex Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to Caileigh Dougherty, Director of Investor Relations.
You may begin.
Good morning and thank you for joining our conference call. Today, we will provide an update on the Athenex’s business as well as a review of financial results for the second quarter of 2022.